HitGen Inc.

Affinity screening, Chemical library synthesis, Compound library design, DNA encoded libraries, Drug Discovery, E3 ligases, Early phase R&D, Focused libraries, Hit expansion libraries, Hit identification, Lead generation, Protein production and purification, Screening libraries, fragment-based drug discovery, new molecular entities, structure-based drug design, synthetic therapeutic oligonucleotide, targeted protein degradation